✦ LIBER ✦

Ticlopidine ‘safe and effective’ following coronary stenting

Book ID: 120876060
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1998
Weight: 224 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199811260-00033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiplatelet Effect of Ticlopidine After

Antiplatelet Effect of Ticlopidine After Coronary Stenting

✍ Franz-Josef Neumann; Meinrad Gawaz; Timm Dickfeld; Anne Wehinger; Hanna Walter; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Ticlopidine and subcutaneous heparin as

Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting

✍ Barragan, P. ;Sainsous, J. ;Silvestri, M. ;Bouvier, J. L. ;Comet, B. ;Siméoni, J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Is ticlopidine a necessary component of

Is ticlopidine a necessary component of antiplatelet regimens following coronary artery stenting

✍ Christopher M. Goods; Khaled F. Al-Shalbi; Brian H. Negus; Ming W. Liu; Sanjay S 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Clinical Outcome at Six Months of Corona

Clinical Outcome at Six Months of Coronary Stenting Followed by Ticlopidine Monotherapy

✍ Mathias Elsner MD; Alfred Peifer MD; Michael Drexler MD; Christian Wenzel; Chris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Incidence of thrombocytopenia following

Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine

✍ William C. Dillon; George J. Eckert; James C. Dillon; Michael E. Ritchie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

The incidence of thrombocytopenia with ticlopidine and clopidogrel when used in conjunction with abciximab has not been systematically addressed. We evaluated the rate of thrombocytopenia in patients undergoing intracoronary stent implantation receiving bolus plus infusion of abciximab and either ti

Clopidogrel is more effective than ticlo

Clopidogrel is more effective than ticlopidine for preventing minor myocardial injury after elective coronary stenting

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 76 KB